comparemela.com

Latest Breaking News On - Ronald van vollenhoven - Page 1 : comparemela.com

'Choose wisely': Each biologic for lupus has 'ideal patient profile'

'Choose wisely': Each biologic for lupus has 'ideal patient profile'
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Amsterdam
Noord-holland
Netherlands
Ronald-van-vollenhoven
Justin-cooper-healio
Shenaz-bagha
Byjustin-cooper
Amsterdam-university-medical-center
Genentech
Astrazeneca
Glaxosmithkline
Clinical-rheumatology

CAR T-cell therapy remains the 'hottest story' in lupus, autoimmune disease

CAR T-cell therapy remains the 'hottest story' in lupus, autoimmune disease
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Amsterdam
Noord-holland
Netherlands
Byrob-volansky
Shenaz-bagha
Ronald-van-vollenhoven
Genentech
Amsterdam-medical-center
Amsterdam-rheumatology-center-academic-medical
Clinical-rheumatology
Jason-laday

Congress of Clinical Rheumatology-East celebrates 'milestone' 40th anniversary

Congress of Clinical Rheumatology-East celebrates 'milestone' 40th anniversary
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Michigan
United-states
University-of-pennsylvania
Pennsylvania
Canada
Toronto
Ontario
Florida
Philadelphia
Amsterdam
Noord-holland
Netherlands

Promising Telitacicept Results Reported for Lupus, Sjögren's

Results of a phase 3 trial in Chinese patients with systemic lupus erythematosus showed a significantly greater response rate with telitacicept, compared with placebo.

University-medical-center
Texas
United-states
Amsterdam
Noord-holland
Netherlands
Dallas
China
Milan
Lombardia
Italy
University-of-texas-southwestern-medical-center

vimarsana © 2020. All Rights Reserved.